XpresSpa Group Begins Construction of New XpresCheck™ COVID-19 Testing Facility at Logan International Airport in Boston
October 09 2020 - 8:30AM
XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”),
a health and wellness company, today announced that it has begun
construction of an XpresCheck™ COVID-19 testing facility at Boston
Logan International Airport that is expected to be fully
operational by November.
XpresCheck is currently building a modular
constructed testing facility within the International Arrival area,
pre security Terminal E, that is expected to host seven separate
testing rooms with an anticipated capacity to administer over 400
tests per day. COVID-19 testing options will include a rapid
molecular COVID-19 test, the Polymerase Chain Reaction (PCR) Test,
and the Blood Antibody Test. All three tests are similarly offered
at the XpresCheck locations in JFK International Airport and Newark
Liberty International Airport.
Doug Satzman, XpresSpa CEO, stated, "We are
eager to launch XpresCheck at Boston Logan International Airport,
which will be our third COVID-19 testing facility this fall. We
believe that our current presence in JFK and Newark, and upcoming
expansion to Logan enables us to play an important role in
supporting the return of domestic and international air travel to
pre-pandemic levels by making sure both airport employees and
travelers feel safe and confident when they come to the airport. As
previously indicated, our intention is to continue XpresCheck’s
national expansion and we remain in active discussions with
additional airports for further development of this concept.”
About XpresSpa Group, Inc.
XpresSpa Group, Inc. (Nasdaq: XSPA) is a leading
global health and wellness holding company. XpresSpa Group’s core
asset, XpresSpa, is a leading airport retailer of spa services and
related health and wellness products, with 50 locations in 25
airports globally. Through its XpresTest, Inc. subsidiary, the
Company also provides COVID-19 screening and testing under its
XpresCheck™ brand at JFK International Airport and Newark Liberty
International Airport. To learn more about XpresSpa Group, visit:
www.XpresSpaGroup.com. To learn more about XpresSpa, visit
www.XpresSpa.com. To learn more about XpresCheck, visit
www.XpresCheck.com.
Forward-Looking StatementsThis
press release may contain "forward-looking" statements within the
meaning of Section 27A of the Securities Act of 1933, and Section
21E of the Securities Exchange Act of 1934. These include
statements preceded by, followed by or that otherwise include the
words "believes," "expects," "anticipates," "estimates,"
"projects," "intends," "should," "seeks," "future," "continue," or
the negative of such terms, or other comparable terminology. In
particular, these statements include, without limitation,
statements about our expectations relating to our new XpresCheck™
concept and our ability to open our XpresCheck™ location at Boston
Logan International Airport on a timely and cost-efficient basis,
being able to expand testing to other communicable diseases as well
as administer vaccinations for the seasonal flu, our positioning to
be part of the national rollout of a COVID-19 vaccination when it
becomes available (including whether such vaccination becomes
available in the near term or at all), the degree to which our
public testing model assists passengers meet testing requirements
in select states and countries, our ability to identify and gain
access to the latest and best COVID-19 testing methodologies and
equipment, and our ability further expand our initial sites,
including at JFK International Airport and Newark Liberty
International Airport as well as Boston Logan International Airport
as we currently expect, and our overall ability to manage the
regulatory challenges associated with this business line.
Forward-looking statements relating to expectations about future
results or events are based upon information available to XpresSpa
Group as of today's date and are not guarantees of the future
performance of the company, and actual results may vary materially
from the results and expectations discussed. Additional information
concerning these and other risks is contained in XpresSpa Group’s
most recently filed Annual Report on Form 10-K, Quarterly Report on
Form 10-Q, recent Current Reports on Form 8-K and other Securities
and Exchange Commission filings. All subsequent written and oral
forward-looking statements concerning XpresSpa Group, or other
matters and attributable to XpresSpa Group or any person acting on
its behalf are expressly qualified in their entirety by the
cautionary statements above. XpresSpa Group does not undertake any
obligation to publicly update any of these forward-looking
statements to reflect events or circumstances that may arise after
the date hereof.
Investor Relations:ICRRaphael
Gross(203) 682-8253
MediaJulie FergusonJulie@jfprmedia.com(312)
385-0098
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Mar 2024 to Apr 2024
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Apr 2023 to Apr 2024